PXF - ETF AI Analysis

Top Page

Invesco FTSE RAFI Developed Markets ex-U.S. ETF (PXF)

Rating:62Neutral

Price Target:―

The Invesco FTSE RAFI Developed Markets ex-U.S. ETF (PXF) has a solid overall rating, reflecting a balanced mix of strong performers and some areas of potential improvement. Holdings like HSBC and Novartis AG stand out for their robust financial health, positive earnings sentiment, and strategic growth, which significantly boost the fund's appeal. However, stocks like Shell and British American Tobacco, while offering strengths such as operational stability and innovation, face challenges like short-term technical weaknesses and market-specific risks, which slightly weigh on the ETF's overall score.

Positive Factors

Strong Top Holdings

Several top holdings, such as Banco Santander, Roche, and Nestlé, have delivered strong year-to-date performance, supporting the fund’s overall returns.

Global Diversification

The ETF has exposure to a wide range of countries, including Japan, the UK, and Germany, which helps reduce reliance on any single economy.

Balanced Sector Allocation

The fund is diversified across multiple sectors, with significant exposure to Financials, Industrials, and Consumer Cyclical industries.

Negative Factors

Underperforming Holdings

Some key holdings, such as Toyota Motor and TotalEnergies, have shown weak year-to-date performance, which could weigh on the fund’s returns.

Moderate Expense Ratio

The ETF’s expense ratio is higher than some low-cost alternatives, which may reduce overall returns for investors over time.

Limited U.S. Exposure

With only 10% of assets allocated to U.S. companies, the fund may miss out on growth opportunities in the world’s largest economy.

PXF vs. SPDR S&P 500 ETF (SPY)

AUM2.35B

RegionDeveloped Markets

Expense Ratio0.43%

Beta0.64

IssuerInvesco

Inception DateJun 25, 2007

Dividend Yield3.53%

Asset ClassEquity

Index TrackedRAFI Fundamental Select Developed ex U.S. 1000 Index - Benchmark TR Net

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume66,657

30 Day Avg. Volume66,568

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

71.64

Price Target Upside― Downside

Rating ConsensusHold

Number of Analyst Covering929

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

PXF Summary

The Invesco FTSE RAFI Developed Markets ex-U.S. ETF (PXF) is an investment fund that focuses on companies in developed countries outside the United States, such as Japan, the UK, and Germany. Instead of picking stocks based on their size, it uses a unique strategy that selects companies based on their financial health, like their sales, cash flow, and dividends. Some well-known companies in this ETF include Toyota Motor and Shell. Investors might consider PXF for international diversification and exposure to global markets. However, since it invests in foreign companies, its performance can be affected by currency fluctuations and economic conditions in other countries.

How much will it cost me?The expense ratio for the Invesco FTSE RAFI Developed Markets ex-U.S. ETF (PXF) is 0.43%, meaning you’ll pay $4.30 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed using a fundamental weighting strategy rather than a passive market-cap approach.

What would affect this ETF?The PXF ETF could benefit from economic growth in developed markets outside the U.S., particularly in Europe and Asia, as well as increased demand for energy and industrials, which are key sectors in its portfolio. However, it may face challenges from rising interest rates, which could impact financial sector performance, and geopolitical tensions or regulatory changes in its geographic focus areas. Its reliance on fundamental metrics may help mitigate risks by focusing on companies with strong financial health.

PXF Top 10 Holdings

The Invesco FTSE RAFI Developed Markets ex-U.S. ETF leans heavily on financials, with HSBC and Banco Santander driving strong performance thanks to robust earnings and strategic initiatives. Roche and Novartis add resilience from the healthcare sector, showing steady growth despite valuation concerns. Energy names like Shell and BP are mixed, with Shell holding steady while BP struggles with short-term weakness. The fund’s global focus spans Europe, Asia, and Australia, offering diversified exposure but a tilt toward financial and healthcare giants that are keeping the fund on solid ground despite some lagging energy stocks.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
SHEL	Shell (UK)	1.77%	$41.98M	£151.23B	1.83%	73 Outperform
7203	Toyota Motor	1.23%	$29.16M	¥44.16T	25.23%	80 Outperform
TTE	TotalEnergies SE	1.17%	$27.71M	€119.31B	-2.80%	78 Outperform
ROG	Roche Holding AG	1.15%	$27.27M	CHF273.54B	48.53%	73 Outperform
HSBA	HSBC Holdings	1.15%	$27.19M	£206.52B	51.75%	80 Outperform
GLEN	Glencore	0.96%	$22.70M	£54.84B	27.91%	68 Neutral
BHP	BHP Group Ltd	0.86%	$20.37M	AU$236.16B	29.50%	68 Neutral
BP	BP p.l.c.	0.82%	$19.28M	£65.19B	3.96%	71 Outperform
SAN	Banco Santander	0.78%	$18.54M	€151.70B	128.43%	73 Outperform
NOVN	Novartis AG	0.74%	$17.46M	CHF216.66B	26.11%	80 Outperform

PXF Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

63.88

Positive

100DMA

62.13

Positive

200DMA

58.20

Positive

Market Momentum

MACD

1.06

Negative

RSI

72.19

Negative

STOCH

93.72

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PXF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 65.88, equal to the 50-day MA of 63.88, and equal to the 200-day MA of 58.20, indicating a bullish trend. The MACD of 1.06 indicates Negative momentum. The RSI at 72.19 is Negative, neither overbought nor oversold. The STOCH value of 93.72 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PXF.

PXF Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
PXF	―	―	$2.35B	0.43%	―
GSIE	―	―	$5.13B	0.25%	―
LVHI	―	―	$3.87B	0.40%	―
IMTM	―	―	$3.64B	0.30%	―
INTF	―	―	$2.99B	0.16%	―
IDMO	―	―	$2.62B	0.25%	―

Performance Comparison

PXF

Invesco FTSE RAFI Developed Markets ex-U.S. ETF

67.51

21.03

45.25%

GSIE

Goldman Sachs ActiveBeta International Equity ETF

―

LVHI

Legg Mason International Low Volatility High Dividend ETF

―

IMTM

iShares MSCI Intl Momentum Factor ETF

―

INTF

iShares MSCI Intl Multifactor ETF

―

IDMO

Invesco S&P International Developed Momentum ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents